View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry

Blog

Rep. Diana DeGette (D-CO) Addresses 21st Century Cures at Dpharm


  • July 16, 2014

  • 21st Century Cures is a new initiative that aims to accelerate the pace of cures and medical breakthroughs in the United States. Rep. Diana DeGette (D-CO) and House Energy and Commerce Committee Chairman Fred Upton (R-MI) are leading this initiative. This is a rare effort in Congress and we are thrilled to have Diana DeGette as our keynote and for her to give an update on the progress at DPharm on September 12th in Boston.

    diana degHigh Res 5x7_1

    From ENERGY & COMMERCE COMMITTEE

    A Path to 21st Century Cures Mission

    In the 21st century, health care innovation is happening at lightning speed. From the mapping of the human genome to the rise of personalized medicines that are linked to advances in molecular medicine, we have seen constant breakthroughs that are changing the face of disease treatment, management, and cures. Health research is moving quickly, but the federal drug and device approval apparatus is in many ways the relic of another era. We have dedicated scientists and bold leaders at agencies like the NIH and the FDA, but when our laws don’t keep pace with innovation, we all lose.

    If we want to save more lives and keep this country the leader in medical innovation, we have to make sure there’s not a major gap between the science of cures and the way we regulate these therapies.

    That is why, for the first time ever, we in Congress are going to take a comprehensive look at what steps we can take to accelerate the pace of cures in America. We are looking at the full arc of this process – from the discovery of clues in basic science, to streamlining the drug and device development process, to unleashing the power of digital medicine and social media at the treatment delivery phase.

    We know we don’t have all the answers. That’s why we’re asking questions first. We are listening.  We want to know how to close the gaps between advances in scientific knowledge about cures and the regulatory policies created to save more lives.

    Over the next several months, members will take a comprehensive look at the full arc of this process – from the discovery to development to delivery – to determine what steps we can take to ensure we are taking full advantage of the advances this country has made in science and technology and use these resources to keep America as the innovation capital of the world.

    – See more at: http://energycommerce.house.gov/cures#sthash.b9sN3IrS.dpuf

    For more information on Path to 21st Century Cures: http://theconferenceforum.org/conferences/disruptive-innovations/agenda/#day-22844-tab